Trends of gastric malignancies: Case study of Ibn Sina Hospital 2010-2011
Abstract
Back ground: Gastric malignancies carry poor prognosis, because they commonly present at an
advanced stage.
Objective: to find out mode of presentation and its impact on the outcome and management of
gastric cancer and to find if there are changes in trends of gastric malignancies over the last decade.
Patients and methods: A review of 53 patients with gastric malignancies, treated at Ibn Sina
Hospital from August 2010 through August 2011. Their demographic data, pattern of clinical
presentation, histopathology grading and staging, type of management and hospital mortality were
studied.
Statistical analysis: Data was fed to Statistical Package for Social Sciences. Means and
correlations were computed where appropriate. One sample t-test was performed. Statistical
significance was taken at P = 0.05.
Results: Out of 53 patients males comprise 30(56.6%) males. The peak frequency was at the age
group 55-70 years. Patients from the Northern Region of Sudan constituted 34%. Adenocarcinoma
comprised 43(81.3%), GIST 8(15%), lymphoma 1(1.9%) and carcinoid 1(1.9%). Epigastric pain
was the commonest symptom in 47(88.7%) patients. Smoking and snuff (Tombak) and high salt
diet were found in 7.5% and 5.7% and 3.8% patients respectively. Blood group A and O was found
in 22.6% and 60.4% respectively. Family cancer syndrome was found in 11.3% patients.
Malignancies of the antrum constitute 27(65.85%), cardia 4(9.8%), body 7(17.1%), and whole
stomach 3(7.3%) patients. There were only 6.25% clinically early cases. Potentially curative
resection was attempted in 31.7%. The mean hospital stay was 12 days.
Conclusion: Patients presented at stage III and IV comprise 30 (93.75%) out of 32 carcinoma
patients. The hospital morbidity was 13(24.6%) patients and mortality 4(7.5%) patients. When
compared with results from same hospital there is improvement in outcome over a decade.
References
2. Altekruse SF, Kosary M, Krapcho M et al (eds):SEER cancer statistics Review ,1975-2007,Nationalcancer Institute Bethesda MD.
3. Parkin DM, Stjernsward J and Muir CS. Estimateof the world wide frequency of twelve majorcancer .Bull world health organ, 1984;62(2):P.163-82.
4. Malik MO; Zaki El Din Z; El Masri SH. Cancer ofthe Alimentary tract in Sudan: a study of 546cases, Cancer . 1976 May; 37 (5): 2533 – 42.
5. Khalid Elsir, Abdelmagid M Masaad. M AIbnouf. Audit of advanced gastric cancer atIbn Sina Hospital, Sudan. SudJMS 2006;1(1): 52-57.
6. Parkin DM, Pisani P, and Ferlay J. Estimates ofthe worldwide incidence of 25 major cancers in1990 Int J Cancer, 1999. 80(6): p. 827-41.
7. Dhillon PK, Farrow TC; Vaughan TL et al: Familyhistory of cancer and risk of oesophageal andgastric cancer in United States Int. J. cancer 2001;93: 146 -52.
8. Wai K leung, Fuders KW Ng, Wing Y chan et al:Risk factors associated with the development ofIntestinal Metaplasia in the first degree relatives ofgastric cancer patients. Cancer epidmiology BioMarkers Prev. 2005, 14 (12): 2982 – 2986.
9. Tsugane S: Salt and salted food intake and risk ofgastric cancer epidemiological evidence, cancersci 2005; 96 (1): 1-6.
10. Doll R, Drane H, Newell AC. Secretion of bloodsubstances in Du, Gu, gastric carcinoma and DM.International Journal of gastroenterology andhepatology. Gut. 1961 December; 2 (4) : 352 –359.
11. Schaefer N, Sinning C, standop J et al: treatmentand prognosis of gastric stump carcinoma incomparison with primary proximal gastric cancer;Ann. J. Surg 194: 63, 2007.
12. Sitas F, Yarnell J, Forman D. Helicobacter pyloriinfection rates in relation to ages and social classin apopulation of Wales men. Gut 1992, 33:1583.
13. Mc Coll KE; Watabe H; Derakhshan MH : Roleof gastric atrophy in mediating negativeassociation between Helicobaeter Pylori infectionand reflux oesophagitis; Barret’s oesophagus, andoesophageal Adeno Carcinoma. Gut 57: 721,2008. Freedman LS, Edwards BK, Ries LAG et al.Eds 2006. Cancer incidence in four membersCountries Cyprus, Egypt, Israel and Jordan ofMiddle East – Cancer consortium (MECCcompared with US. SEER: Bethesda NationalCancer Institute (NCI) pp 14.
14. Deng J, Liang H, Sun D, et al. prognosis ofgastric cancer patients with node negativemetastasis following curative resection outcomeof survival and recurrence. Can j gastroenterol2008; 22(10):835-839.
15. Shiraishi N, Sato K, Yasuda K, et al. Multivariateprognostic study on large gastric cancer. J SurgOncol. 2007 Jul 1;96 (1):14-8.
16. Fukuda N, Sugiyama Y, Wada J. Prognosticfactors of T4 gastric cancer patients undergoingpotentially curative resection. World JGastroenterol. 2011 Mar 7; 17(9): 1180-4.
17. Kim DY, Joo JK, Seo KW, et al. T4 Gastriccarcinoma: the benefit of non-curative resection.ANZ J Surg. 2006.